Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alkermes plc.ALKS · Entity 2392 | Director | May 20, 2026 | May 23, 2026 |
| CABOT CORPCBT · Entity 4032 | Director | January 08, 2026 | January 12, 2026 |
| NOVANTA INCNOVT · Entity 3857 | Director | January 02, 2026 | January 06, 2026 |
| REVVITY, INC.PKI · Entity 3382 | Please See Remarks | March 05, 2018 | March 06, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alkermes plc.
Report date May 20, 2026 · Filed May 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 35,751 |
Ending reported balance
After 2026-05-21 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-05-21 · Exercise / conversion · Acquired 6,142 · Balance 37,226 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. Row 2 · 2026-05-21 · Tax withholding · Disposed 1,475 · Balance 35,751 |
| Non Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.98 · Expires 2036-05-20 | Direct | 11,538 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 11,538 · Balance 11,538 F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 5,409 |
Reported balance
After 2026-05-20 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-20 · Grant · Acquired 5,409 · Balance 5,409 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant. |
| Restricted Stock Unit AwardSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-05-21 · Exercise / conversion · Disposed 6,142 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one ordinary share. F3: This award is fully vested in accordance with its terms. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one ordinary share.
F2: Shares subject to the award vest (and if applicable, become exercisable) in full on the earlier of the one-year anniversary of the date of grant or the date of the issuer's next annual general meeting of shareholders that occurs at least 50 weeks after the date of grant.
F3: This award is fully vested in accordance with its terms.
CABOT CORP
Report date January 08, 2026 · Filed January 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,552 |
Reported balance
After 2026-01-08 transaction · row 1
1 source rowRow 1 · 2026-01-08 · Grant · Acquired 2,298 · Balance 18,552 F1: The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan.
NOVANTA INC
Report date January 02, 2026 · Filed January 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,947 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Exercise / conversion · Acquired 1,325 · Balance 3,947 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-01-02 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-01-02 · Exercise / conversion · Disposed 1,325 · Balance 0 F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,799 |
Reported balance
After 2026-01-02 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-01-02 · Grant · Acquired 1,799 · Balance 1,799 F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On January 2, 2026, the RSUs were settled in Novanta Inc. common shares.
F2: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date).
F3: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date.
REVVITY, INC.
Report date March 05, 2018 · Filed March 06, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 93,624 |
Reported balance
After 2018-03-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-03-05 · Exercise / conversion · Acquired 31,699 · Balance 93,624 |
| Common StockSEC Table I · non-derivative | Direct | 128,738 |
Reported balance
After 2018-03-05 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-03-05 · Exercise / conversion · Acquired 35,114 · Balance 128,738 |
| Common StockSEC Table I · non-derivative | Direct | 156,754 |
Reported balance
After 2018-03-05 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2018-03-05 · Exercise / conversion · Acquired 28,016 · Balance 156,754 |
| Common StockSEC Table I · non-derivative | Direct | 165,581 |
Reported balance
After 2018-03-05 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2018-03-05 · Exercise / conversion · Acquired 8,827 · Balance 165,581 |
| Common StockSEC Table I · non-derivative | Direct | 109,654 |
Reported balance
After 2018-03-05 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2018-03-05 · Sale · Disposed 55,627 · Balance 109,654 F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018. F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $73.05 to $74.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. |
| Common StockSEC Table I · non-derivative | Direct | 61,925 |
Reported balance
After 2018-03-05 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2018-03-05 · Sale · Disposed 48,029 · Balance 61,925 F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018. F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $74.06 to $74.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F4: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.01 · Expires 2021-02-21 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-03-05 · Exercise / conversion · Disposed 31,699 · Balance 0 F5: This option became exercisable in three equal annual installments beginning on February 4, 2015, which was the first anniversary of the date on which the option was granted. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.26 · Expires 2022-02-03 | Direct | 0 |
Reported balance
After 2018-03-05 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-03-05 · Exercise / conversion · Disposed 35,114 · Balance 0 F6: This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $41.80 · Expires 2023-02-09 | Direct | 14,008 |
Reported balance
After 2018-03-05 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2018-03-05 · Exercise / conversion · Disposed 28,016 · Balance 14,008 F7: This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted. |
| NQ Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.65 · Expires 2024-02-07 | Direct | 17,654 |
Reported balance
After 2018-03-05 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2018-03-05 · Exercise / conversion · Disposed 8,827 · Balance 17,654 F8: This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018.
F2: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $73.05 to $74.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $74.06 to $74.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
F4: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account.
F5: This option became exercisable in three equal annual installments beginning on February 4, 2015, which was the first anniversary of the date on which the option was granted.
F6: This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted.
F7: This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted.
F8: This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SPARTON CORP
Report date March 04, 2019 · Filed March 04, 2019
Section 16 reporting ended · disclosed 2019-03-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-04 transaction · row 1
1 source rowRow 1 · 2019-03-04 · Disposition to issuer · Disposed 7,972 · Balance 0 F1: Disposed of pursuant to Agreement and Plan of Merger dated as of December 11, 2018, by and among Sparton Corporation, Sparton Parent, Inc. and Striker Merger Sub 2018, Inc. in exchange for $18.50 per share in cash, without interest. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to Agreement and Plan of Merger dated as of December 11, 2018, by and among Sparton Corporation, Sparton Parent, Inc. and Striker Merger Sub 2018, Inc. in exchange for $18.50 per share in cash, without interest.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 14, 2022 Filed Jun 16, 2022 20:59 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 7,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-017640 · form4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:59 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 695 | $27.19 | $18,897.05 |
DisclosureSEC source: 0001127602-22-017640 · form4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,829 Read SEC document |
| June 14, 2022 Filed Jun 16, 2022 20:59 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 7,585 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-017640 · form4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 13, 2022 Filed May 16, 2022 20:27 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionRestricted Stock Units · Derivative | 304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-014649 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 304 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 13, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 13, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 13, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.exercise_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 13, 2022, the RSUs were settled in Novanta Inc. common shares. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 13, 2022, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| May 13, 2022 Filed May 16, 2022 20:27 UTC | NOVANTA INC NOVT · Entity 3857 | Exercise / conversionCommon Stock | 304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-014649 · form4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") was the economic equivalent of one Novanta Inc. common share. On May 13, 2022, the RSUs were settled in Novanta Inc. common shares. Read SEC document |
| April 05, 2022 Filed Apr 7, 2022 20:51 UTC | NOVANTA INC NOVT · Entity 3857 | GrantDeferred Stock Units · Derivative | 40 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-011731 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 703 Underlying: Common Stock · 40 shares Expires not disclosed F1 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F1 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F1 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F1 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| January 13, 2022 Filed Jan 14, 2022 21:23 UTC | CABOT CORP CBT · Entity 4032 | GrantCommon Stock | 2,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-003340 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,577 F1 · shares: The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:46 UTC | NOVANTA INC NOVT · Entity 3857 | GrantDeferred Stock Units · Derivative | 359 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-000894 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 663 Underlying: Common Stock · 359 shares Expires not disclosed F3 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F3 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F3 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. F3 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of issuer common stock. The Deferred Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:46 UTC | NOVANTA INC NOVT · Entity 3857 | GrantRestricted Stock Units · Derivative | 359 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-000894 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 359 Underlying: Common Stock · 359 shares Expires not disclosed F1 · security: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F1 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. F1 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:27 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030304 · form4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:27 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,339 | $22.11 | $29,605.29 |
DisclosureSEC source: 0001127602-21-030304 · form4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,939 Read SEC document |
| December 02, 2021 Filed Dec 4, 2021 02:27 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 5,578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-030304 · form4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,278 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:29 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 7,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-020047 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 Underlying: Ordinary Shares · 7,585 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 6/14/2022. Read SEC document |
| June 14, 2021 Filed Jun 16, 2021 20:29 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 15,677 | $0.00 Strike: $24.72 | $0.00 |
DisclosureSEC source: 0001127602-21-020047 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,677 Underlying: Ordinary Shares · 15,677 shares Expires 2031-06-14 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 6/14/2022. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:40 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017791 · form4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This restricted stock unit award vested in full on 5/20/2021. F1 · derivative.expiration_date: This restricted stock unit award vested in full on 5/20/2021. Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:40 UTC | Alkermes plc. ALKS · Entity 2392 | Tax withholdingOrdinary Shares | 1,404 | $21.92 | $30,775.68 |
DisclosureSEC source: 0001127602-21-017791 · form4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
| May 20, 2021 Filed May 21, 2021 20:40 UTC | Alkermes plc. ALKS · Entity 2392 | Exercise / conversionOrdinary Shares | 6,104 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-017791 · form4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2021 Filed May 14, 2021 16:51 UTC | NOVANTA INC NOVT · Entity 3857 | GrantDeferred Stock Units · Derivative | 304 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-21-016737 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304 Underlying: Common Stock · 304 shares Expires not disclosed F3 · derivative.exercise_price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. F3 · price: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. F3 · derivative.exercise_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. F3 · derivative.expiration_date: As of the date the reporting person ceases to be a director of the issuer, each Deferred Stock Unit will convert into a share of Issuer common stock. Read SEC document |
| May 13, 2021 Filed May 14, 2021 16:51 UTC | NOVANTA INC NOVT · Entity 3857 | GrantRestricted Stock Units · Derivative | 304 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-016737 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 304 Underlying: Common Stock · 304 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F1 · derivative.exercise_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.exercise_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. F1 · derivative.expiration_date: Each Restricted Stock Unit represents the right to receive one Novanta Inc. common share on the first anniversary of the Grant Date (or, if such date is not a business day, on the first business day immediately following the first anniversary of the Grant Date). F2 · derivative.expiration_date: The Restricted Stock Units were fully vested and non-forfeitable on the Grant Date. Read SEC document |
| January 07, 2021 Filed Jan 11, 2021 22:34 UTC | CABOT CORP CBT · Entity 4032 | GrantCommon Stock | 2,489 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-003028 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,323 F1 · shares: The shares have been deferred pursuant to Cabot's Non-Employee Directors' Deferral Plan. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:38 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 5,578 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-030581 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,578 Underlying: Ordinary Shares · 5,578 shares Expires not disclosed F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 12/2/2021. Read SEC document |
| December 02, 2020 Filed Dec 4, 2020 21:38 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,509 | $0.00 Strike: $18.82 | $0.00 |
DisclosureSEC source: 0001127602-20-030581 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,509 Underlying: Ordinary Shares · 11,509 shares Expires 2030-12-02 F1 · derivative.exercise_date: This option becomes exercisable in full on 12/2/2021. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:25 UTC | Alkermes plc. ALKS · Entity 2392 | GrantRestricted Stock Unit Award · Derivative | 6,104 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017777 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,104 Underlying: Ordinary Shares · 6,104 shares Expires not disclosed F1 · shares: This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/20/2021. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/20/2021. Read SEC document |
| May 20, 2020 Filed May 22, 2020 20:25 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 12,823 | $0.00 Strike: $16.85 | $0.00 |
DisclosureSEC source: 0001127602-20-017777 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,823 Underlying: Ordinary Shares · 12,823 shares Expires 2030-05-20 F1 · shares: This option and restricted stock unit award together represent 50% of the approved value of the non-employee director annual equity grant. The remaining portion of such grant has been delayed, and is subject to downward adjustment, due to the uncertainty posed by the COVID-19 pandemic. F2 · derivative.exercise_date: This option becomes exercisable in full on 5/20/2021. Read SEC document |
| January 09, 2020 Filed Jan 13, 2020 19:56 UTC | CABOT CORP CBT · Entity 4032 | GrantCommon Stock | 2,635 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-003176 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,834 Read SEC document |
| December 04, 2019 Filed Dec 9, 2019 21:14 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 61,800 | $0.00 Strike: $21.23 | $0.00 |
DisclosureSEC source: 0001127602-19-034551 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,800 Underlying: Ordinary Shares · 61,800 shares Expires 2029-12-04 F1 · date: Late filing due to administrative error. F3 · derivative.exercise_date: This option vests in 3 equal annual installments commencing on 12/4/2020. Read SEC document |
| December 04, 2019 Filed Dec 9, 2019 21:14 UTC | Alkermes plc. ALKS · Entity 2392 | GrantNon Qualified Stock Option (Right to Buy) · Derivative | 11,200 | $0.00 Strike: $21.23 | $0.00 |
DisclosureSEC source: 0001127602-19-034551 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Ordinary Shares · 11,200 shares Expires 2029-12-04 F1 · date: Late filing due to administrative error. F2 · derivative.exercise_date: This option becomes exercisable in full on 12/4/2020. Read SEC document |
| March 04, 2019 Filed Mar 4, 2019 18:47 UTC | SPARTON CORP SPA · Entity 159664 | Disposition to issuerCommon Stock | 7,972 | $18.50 | $147,482.00 |
DisclosureSEC source: 0001736749-19-000021 · primary_doc.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Disposed of pursuant to Agreement and Plan of Merger dated as of December 11, 2018, by and among Sparton Corporation, Sparton Parent, Inc. and Striker Merger Sub 2018, Inc. in exchange for $18.50 per share in cash, without interest. Read SEC document |
| January 10, 2019 Filed Jan 14, 2019 21:59 UTC | CABOT CORP CBT · Entity 4032 | GrantCommon Stock | 2,613 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-003583 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,199 Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 17:52 UTC | CABOT CORP CBT · Entity 4032 | GrantCommon Stock | 586 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-051181 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 586 Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 8,827 | $0.00 Strike: $52.65 | $0.00 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · derivative · entry 10 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,654 Underlying: Common Stock · 8,827 shares Expires 2024-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 7, 2018, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 28,016 | $0.00 Strike: $41.80 | $0.00 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · derivative · entry 9 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,008 Underlying: Common Stock · 28,016 shares Expires 2023-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 9, 2017, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 35,114 | $0.00 Strike: $46.26 | $0.00 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · derivative · entry 8 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,114 shares Expires 2022-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 31,699 | $0.00 Strike: $43.01 | $0.00 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · derivative · entry 7 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,699 shares Expires 2021-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 4, 2015, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 48,029 | $74.28 | $3,567,594.12 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · nonDerivative · entry 6 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,925 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018. F3 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $74.06 to $74.66. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F4 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 55,627 | $73.64 | $4,096,372.28 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · nonDerivative · entry 5 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,654 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on January 30, 2018. F2 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $73.05 to $74.05. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 8,827 | $52.65 | $464,741.55 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · nonDerivative · entry 4 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 28,016 | $41.80 | $1,171,068.80 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · nonDerivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 35,114 | $46.26 | $1,624,198.07 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,738 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2018 Filed Mar 6, 2018 22:31 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 31,699 | $43.01 | $1,363,373.99 |
DisclosureSEC source: 0000899243-18-006499 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | Tax withholdingCommon Stock | 3,217 | $78.08 | $251,183.36 |
DisclosureSEC source: 0000899243-18-003087 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,925 F1 · shares: These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 5, 2013, as required by the Reporting Person's Restricted Stock Agreement. F2 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 29,052 | $0.00 Strike: $33.87 | $0.00 |
DisclosureSEC source: 0000899243-17-028237 · doc4.xml · derivative · entry 5 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,052 shares Expires 2020-02-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 5, 2014, which was the first anniversary of the date on which the option was granted. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 41,439 | $0.00 Strike: $26.15 | $0.00 |
DisclosureSEC source: 0000899243-17-028237 · doc4.xml · derivative · entry 4 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,439 shares Expires 2019-02-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 7, 2013, which was the first anniversary of the date on which the option was granted. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 37,535 | $70.14 | $2,632,704.90 |
DisclosureSEC source: 0000899243-17-028237 · doc4.xml · nonDerivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,142 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on November 7, 2017. F2 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $70.00 to $70.40. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F3 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 29,052 | $33.87 | $983,991.24 |
DisclosureSEC source: 0000899243-17-028237 · doc4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,633 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| December 07, 2017 Filed Dec 8, 2017 21:05 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 41,439 | $26.15 | $1,083,422.66 |
DisclosureSEC source: 0000899243-17-028237 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:10 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionNQ Stock Option (right to buy) · Derivative | 37,535 | $0.00 Strike: $26.58 | $0.00 |
DisclosureSEC source: 0000899243-17-007615 · doc4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,535 shares Expires 2018-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option became exercisable in three equal annual installments beginning on February 8, 2012, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:10 UTC | REVVITY, INC. PKI · Entity 3382 | SaleCommon Stock | 37,535 | $55.45 | $2,081,390.82 |
DisclosureSEC source: 0000899243-17-007615 · doc4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,141 F1 · kind: The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by Mr. Wilson on February 10, 2017. F2 · price: The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $55.310 to $55.633. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F3 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| March 13, 2017 Filed Mar 15, 2017 20:10 UTC | REVVITY, INC. PKI · Entity 3382 | Exercise / conversionCommon Stock | 37,535 | $26.58 | $997,680.30 |
DisclosureSEC source: 0000899243-17-007615 · doc4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · balance_after: The Reporting Person's direct holdings include shares acquired pursuant to the Reporting Person's (i) election to defer stock and/or compensation into the Deferred Compensation Plan, and/or (ii) reinvestment of dividends relating to the Reporting Person's account. Read SEC document |
| February 07, 2017 Filed Feb 8, 2017 22:33 UTC | REVVITY, INC. PKI · Entity 3382 | GrantNQ Stock Option (right to buy) · Derivative | 26,481 | $0.00 Strike: $52.69 | $0.00 |
DisclosureSEC source: 0000899243-17-003144 · doc4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Please See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,481 Underlying: Common Stock · 26,481 shares Expires 2024-02-07 F4 · derivative.exercise_date: This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.